论文部分内容阅读
各有关单位:2009-2011年,医药行业总产值实现了21%左右的增长,继续维持了新医改前的平稳高速增长态势;预计“十二五”期间仍可保持20%的增长速度,2015年工业总产值将超过3万亿元。目前中国已经成为全球第三大医药市场。国家对药品依法监管的力度逐渐加大,国家药品监督管理部门近年发布的系列医药行业《规范》作为医药生产企业、医药流通企业的准入标准,起到了净化整个医药行业的作用。
Relevant units: From 2009 to 2011, the total output value of the pharmaceutical industry witnessed a growth of about 21%, maintaining the steady and rapid growth before the new medical reform. It is estimated that the growth rate of 20% during the “12th Five-Year Plan” will be maintained In 2015, the total industrial output value will exceed 3 trillion yuan. At present, China has become the third largest pharmaceutical market in the world. The state has gradually stepped up the supervision over the drug according to law. The “Regulation” of the series of pharmaceutical industry released by the State Drug Administration in recent years has played a role of purifying the entire pharmaceutical industry as a standard for admittance of pharmaceutical manufacturing enterprises and pharmaceutical distribution enterprises.